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In spite of growing evidence supporting the occurrence of complex interactions between
Schistosoma and gut bacteria in mice and humans, no data is yet available on whether
worm-mediated changes in microbiota composition are dependent on the baseline gut
microbial profile of the vertebrate host. In addition, the impact of such changes on the
susceptibility to, and pathophysiology of, schistosomiasis remains largely unexplored. In
this study, mice colonized with gut microbial populations from a human donor (HMA
mice), as well as microbiota-wild type (WT) animals, were infected with Schistosoma
mansoni, and alterations of their gut microbial profiles at 50 days post-infection were
compared to those occurring in uninfected HMA and WT rodents, respectively.
Significantly higher worm and egg burdens, together with increased specific antibody
responses to parasite antigens, were observed in HMA compared to WT mice. These
differences were associated to extensive dissimilarities between the gut microbial profiles
of each HMA and WT groups of mice at baseline; in particular, the gut microbiota of HMA
animals was characterized by low microbial alpha diversity and expanded Proteobacteria,
as well as by the absence of putative immunomodulatory bacteria (e.g. Lactobacillus).
Furthermore, differences in infection-associated changes in gut microbiota composition
were observed between HMA and WT mice. Altogether, our findings support the
hypothesis that susceptibility to S. mansoni infection in mice is partially dependent on
the composition of the host baseline microbiota. Moreover, this study highlights the
applicability of HMA mouse models to address key biological questions on host-parasite-
microbiota relationships in human helminthiases.
Keywords: helminth-gut microbiota interactions, Schistosoma mansoni, human-microbiota associated mouse
models, gut microbial diversity, dysbiosis, immune-modulationorg November 2020 | Volume 11 | Article 5938381
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The study of the interactions between the residentmicrobiota of the
vertebrate gut and both enteric and non-enteric parasitic worms is
emerging as a key area of research (1–3). Indeed, over the last
decade, several studies performed under both experimental and
natural conditions of parasite infections, have provided evidence of
quantitative and qualitative changes in populations of gut and/or
fecal bacterial communities associatedwithwormestablishment (4,
5). Some of these studies have shown that infection-associated
alterations of the host gut microbiota impact on the pathogenesis
and pathophysiology of helminthiases, e.g. via changes to worm
burdens (6) and effects on parasite immune-modulatory properties
(6–9). Other investigations suggest that the host gut flora
contributes to the gastrointestinal pathology associated with
helminth infection (10, 11). Nonetheless, disentangling the
immune-molecular mechanisms that underpin these interactions
is essential for establishing causal relationships between helminths
and the gut microbiota. In addition, such knowledge will assist the
development of intervention strategies for parasite control, and/or
of novel therapeutics for the prevention and treatment of chronic
inflammatory diseases, based on the rational manipulation of the
host gut microbiota (12).
The causative agents of the major neglected tropical disease
schistosomiasis are blood flukes (i.e. trematodes) of the genus
Schistosoma, that includes S. mansoni, S. haematobium and S.
japonicum among other, less prevalent, species (13). More than
250 million people are estimated to be infected with these parasites
worldwide, mainly in tropical impoverished areas (13). In addition
to the hepato-intestinal disease associated with S. mansoni and S.
japonicum, and the urogenital pathology caused by S.
haematobium, which includes bladder cancer, all forms of
schistosomiasis are associated with systemic morbidities that
include malnutrition, anemia, physical and/or cognitive
impairment and stunted development in children (13). Over the
last few years, a number of studies have demonstrated that
infections by Schistosoma spp. are associated with quantitative
and qualitative alterations of the gut microbial profiles of both
humans (14–18) and experimentally-infected mice (10, 19–21). In
particular, experiments conducted in murine models of hepato-
intestinal schistosomiasis (i.e. by S. mansoni and S. japonicum,
whose eggs penetrate the intestinal wall and are released into the
environment via the feces) have suggested that, while both egg-
related and -unrelated mechanisms contribute to the interactions
between Schistosoma parasites and the host gut microbiota, the
former exert a greater impact on intestinal microbial communities
(19–21). In support of this hypothesis, we have previously reported
dramatic changes in the gut microbiota profile of mice
experimentally infected with S. mansoni cercariae that, while
detectable during the pre-patent period, were most evident
following the onset of egg-laying (19). In particular, features of
microbial dysbiosis, including reduced alpha diversity andAbbreviations: ASV, Amplicon Sequence Variant; EPG, Eggs per gram; HMA,
Human microbiota-associated; SCFA, Short Chain Fatty Acid; SEA, Soluble egg
antigen; Sm-exp, Exposed to Schistosoma mansoni cercariae; Sm-, Uninfected;
Sm+, Infected with Schistosoma mansoni; WT, Wildtype.
Frontiers in Immunology | www.frontiersin.org 2expansion of proinflammatory bacteria were observed during the
patent phase of infection (19). In addition, Floudas et al. (20) have
shown that perturbations in gutmicrobiota compositionweremore
extensive in mice infected with mixed-sex S. mansoni than in mice
colonized by single-sex (male) worms.
While the causality of Schistosoma-microbiome interactions
remains unclear, it seems plausible that quantitative and qualitative
changes in the host gut flora upon parasite colonization may
contribute to the pathophysiology of schistosomiasis (10, 19, 21).
However, experimental data on the impact of Schistosoma parasites
on the host gut microbiota originate from studies conducted in wild
type mouse models of infection, and no information is available on
possible variations that changes in baseline microbiota communities
might introduce into these systems. Determining whether the
baseline gut microbiota composition of the vertebrate host affects
the magnitude of changes observed upon Schistosoma infection is
nonethelesspivotal, as itunderpins the translatabilityoffindings from
mice to humans. In this study, we assessed quantitative and
qualitative changes in gut microbiota composition of mice pre-
colonized with a microbiome of human origin (i.e. human
microbiota-associated [HMA] mice) following experimental
infections with S. mansoni cercariae, and compared the findings
with those observed in wild type (WT) animals. Strikingly, higher
worm and egg burdens were observed in HMA mice compared to
WTanimals, and thesefindingswere associatedwith specific changes
in the microbiota composition of each rodent line.MATERIALS AND METHODS
Ethics Statement
The life cycle of S. mansoni (NMRI strain) is maintained at the
Wellcome Sanger Institute (WSI) by breeding and infecting
susceptible snails (Biomphalaria grabrata) and mice. All mouse
infections and regulated procedures described in this study were
presented to and approved by the Animal Welfare and Ethical
Review Body (AWERB) of the WSI. All experiments were
conducted under the Home Office Project Licenses (Procedure
Project License - PPL) No. P77E8A062 held by GR, and No.
P6D3B94CC held by TL. The AWERB is constituted as required
by the UK Animals (Scientific Procedures) Act 1986
Amendment Regulations 2012.
Generation of Human Microbiota-
Associated Mice and Experimental
Infections
The HMA mouse line was generated at the WSI. Briefly, fresh
feces from a healthy human donor, processed within 1 h from
transportation to the laboratory, were homogenized at 100 mg/
ml in 1x D-PBS in an anaerobic cabinet (80% CO2, 10% H2, 10%
N2). Five male and five female C57BL/6 germ-free mice, bred at
the WSI, were inoculated by oral gavage with 200 ml of donor
homogenates once a week, for 3 weeks. One week after the final
gavage, mice were set up as breeding pairs in a decontaminated
positive pressure isolator. Mice used in this study belonged to the
4th generation of breeding animals. All consumables that enteredNovember 2020 | Volume 11 | Article 593838
Corté s et al. Gut Microbiome and Schistosoma Infectionsthe isolator for maintenance of the colony were autoclaved at
121°C for 15 min. Feces from parental HMA mice (i.e. germ-free
transplanted with human feces) were analyzed by 16S rRNA gene
amplicon sequencing, in order to confirm engraftment of the
human flora (unpublished data). Animals used for experiments
were removed from the isolator in sealed ISOcages and
maintained on a positive pressure ISOrack (Tecniplast).
A total of 10HMAand 10WT (C57BL/6, bred at theWSI)mice
were exposed to 80 S. mansoni cercariae (Sm-exp), as described
previously (22), andmaintained for 50 days with access to food and
water ad libitum. Additionally, 6 WT and HMA mice were kept
uninfected and used as negative controls (Sm-). Experimental
infections, with matched uninfected controls, were performed in
two independent batches (B1 and B2), as indicated in Table 1.Sample Collection and Parasitological
Analyses
Serum samples were obtained from blood collected by puncture of
the tail vein at days 28, 42, and 49 post-cercarial exposure (p.i.). at
days 28, 42, and 49 post-infection. At day 50 p.i., Sm-expmice were
euthanized, S. mansoni adult worms were recovered by portal
perfusion, and livers removed for parasite egg counts (22). Briefly,
liver sections from the right lobe were weighed and digested
overnight in 3 ml of freshly prepared 4% KOH in 1x PBS, at 37°C
under gentle agitation. Eggs were counted in 20 aliquots of 10 µl
each, and the numberof eggs per gram (EPG)of liverwas calculated
by extrapolating the mean number of eggs per aliquot to the total
volume, and dividing by the weight of liver tissue employed
(Supplementary Table 1). Female fecundity, i.e. estimation of the
number of eggs produced by individual femaleworms,was assessed
by dividing the EPG of liver by the total number of female worms
collected from each mouse. Statistically significant differences in
worm burdens and EPG of liver between infected (Sm+) WT and
HMA mice were assessed by unpaired two-tailed t-test, followingFrontiers in Immunology | www.frontiersin.org 3the application of the Kolmogorov-Smirnov normality test for
assessment of normal distribution of worm and egg counts
datasets; differences in female fecundity were evaluated by Mann-
Whitney test. Control Sm- mice were perfused under the same
conditions as Sm-exp animals and the perfusates were discarded.
For microbiota profiling, fecal pellets were collected directly from
the colons of Sm-exp and Sm-mice of each line (i.e.WT andHMA)
at necropsy. Sampleswere transferred to sterile tubes, snap frozen in
dry ice, and stored at −80°C until DNA isolation, which was
performed within 3 weeks from sample collection.
Specific Antibody Detection
Asubset ofmice, including six Sm+and three Sm- animals fromeach
HMA and WT groups were randomly selected to investigate the
kinetics of S.mansoni-specific antibodies. Endotoxin-free soluble egg
antigen (SEA) was generated from S. mansoni eggs isolated from
trypsinized livers of infected mice, as previously described (23). The
presence of IgG (total, IgG1, IgG2b, IgG2c and IgG3), and IgM
reactive against SEA inmouse serumwas determined by ELISA (24).
Briefly, 96well plateswere coatedwith5mg/ml SEAovernight, before
blocking for 1h at room temperature with 1x PBS containing 1%
bovine serum albumin (BSA, Sigma). After blocking, and between
each incubation step, plateswerewashed5 timeswithPBScontaining
0.05%Tween-20 (Sigma). Fiftymicroliters of diluted serum (1:1,000;
PBS+1% BSA) were added to antigen coated wells and incubated for
1h at room temperature. SEA-specific isotypes were detected using
alkaline phosphatase-conjugated goat anti-mouse IgG1, IgG2b,
IgG2c, IgG3, or IgM antibodies (Southern Biotech). Bound IgG or
IgM were detected by adding liquid p-nitrophenyl phosphate
substrate (Southern Biotech), with absorbance read at 405 nm.
Additionally, total serum IgE was measured using paired capture
and detection antibodies (BD-Biosciences), and quantity was
assessed via standard curve. Statistically significant differences in
serum antibody levels between Sm+ and Sm- mice of each WT and
HMAweredeterminedat eachp.i. timepoint byMann-Whitney test.TABLE 1 | Numbers of wild type (WT) and human microbiota-associated mice (HMA) successfully infected by Schistosoma mansoni and left uninfected, and number of
samples from each rodent line processed for downstream parasitological and microbiota analyses.
Mouse
line
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bExperimental infections were carried out in two independent batches (i.e. B1 and B2); each experiment included uninfected mice (negative controls).
cMice successfully infected with S. mansoni (Sm+) or left uninfected (Sm-) at 50 days post-cercarial exposure. *Sm- = mice exposed to S. mansoni cercariae from which no adult worms
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Gene Sequencing
Genomic DNA was isolated from fecal samples and (no-DNA
template) negative controls, using the PowerSoil DNA IsolationKit
(Qiagen) according to manufacturers’ instructions. A total of 28
samples including eight WT and eight HMA Sm+ (selected based
on highest DNA concentration and quality), sixWT and six HMA
Sm-mice, as well as four negative controls were processed for high-
throughput sequencing of the bacterial 16S rRNA gene (Table 1).
Sequencing libraries were prepared following the Illumina
recommendations for bacterial 16S rRNA library preparation,
with minor modifications. Briefly, the V3-V4 region of the
bacterial 16S rRNA gene was amplified by conventional PCR
using universal primers (25) containing the Illumina adapter
o v e r h a n g n u c l e o t i d e s e q u e n c e s ( F o r w a r d : 5 ’
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTAC
GGGNGGCWGCAG; Reverse: 5 ’ GTCTCGTGGGCTC
GGAGATGTGTATAAGAGACAGGACTACHVGGGTAT
CTAATCC), Q5® NEBNext Hot Start High-Fidelity DNA
Polymerase (New England Biolabs), 5 ng/ml of template DNA and
the following thermocycling protocol: 98°C for 2 min, 20 cycles of
98°C/15 s - 63°C/30 s - 72°C/30 s, andafinal elongation step at 72°C
for 5 min. Amplicons were purified using AMPure XP beads
(Beckman Coulter) and set up for the index PCR using Q5®
NEBNext Hot Start High-Fidelity DNA Polymerase (New
England Biolabs) and Nextera XT index primers (Illumina) with
thermocycling conditions as follows: 3 min at 95°C, eight cycles of
30 s at 95°C – 30 s at 55°C – 30 s at 72°C, and 5min at 72°C. The
indexed samples were purified using AMPure XP beads, quantified
usingQubit™ dsDNAHigh Sensitivity Kit (Life Technologies) and
equal DNA amounts from each sample were pooled. The resulting
pooled library was quantified using the NEBNext® Library
Quantification Kit for Illumina® (New England Biolabs), and
sequenced using the v3 chemistry (2x300 bp paired-end reads,
Illumina). DNA isolation and sequencing were performed
separately for samples collected from each B1 and B2 mice (Table
1). Raw sequence data are available from the European Nucleotide
Archive (ENA) database under accession number PRJEB40559,
whilst curated data can be accessed viaMICHELINdb (26).
Bioinformatics and Statistical Analyses
Paired-end demultiplexed Illumina sequencing reads were
imported into the Quantitative Insights Into Microbial Ecology
2 (QIIME 2; 2019.4 distribution, https://qiime2.org) software
suite for downstream analysis (27). Sequences were then quality
filtered, dereplicated, chimeras identified, and paired-end reads
merged in QIIME2 using DADA2 (28); quality filtering was
performed using default settings, trimming was set at position 10
(forward and reverse), and truncation lengths were set at 250 and
240 for forward and reverse, respectively. A phylogenetic tree
was generated using the align-to-tree-mafft-fasttree pipeline in
the q2-phylogeny plugin. Bray-Curtis dissimilarity between
samples was calculated using core-metrics-phylogenetic
method from the q2-diversity plugin. Classification of
Amplicon Sequence Variants (ASVs) was performed using a
naïve Bayes algorithm trained using sequences representing the
bacterial V3-V4 rRNA region available from the SILVA databaseFrontiers in Immunology | www.frontiersin.org 4(https://www.arb-silva.de/download/archive/qiime; Silva_132-
99) (29), and the corresponding taxonomic classifications were
obtained using the q2-feature-classifier plugin in QIIME2. The
classifier was then employed to assign taxonomic information to
representative sequences of each ASV.
Statistical analyses were performed using the Calypso software
(cgenome.net/calypso/) (30). Relative abundances of individual
microbial taxa were calculated by total sum normalization (TSS).
Furthermore, for comparative analyses of taxa abundances between
experimental groups, cumulative-sum scaling (CSS) was applied to
the ASV table, followed by log2 transformation (CSS+log) to
account for the non-normal distribution of taxonomic counts
data. Statistical comparisons were performed between samples
collected from uninfected WT and HMA mice, as well as between
Sm+ and Sm- samples of each WT and HMA, as follows.
Unsupervised Principal Coordinates Analysis (PCoA) on Bray-
Curtis dissimilarities and supervised Canonical Correlation
Analysis (CCA) were performed using ‘mouse line’ (i.e. WT and
HMA) and ‘infection status’ (i.e. Sm- and Sm+) as explanatory
variables, respectively. Beta diversity was calculated using Bray-
Curtis dissimilarity and differences between groups were assessed
using Analysis of Similarity (ANOSIM) (31). Differences in gut
microbiota composition between experimental groups were
assessed by ANOVA and by using the Linear discriminant
analysis Effect Size (LEfSe) workflow (32). Correlations between
differentially abundant bacterial genera and worm burdens or EPG
of liver were examined via multiple linear regressions by
incorporating worm burdens (or EPG of liver) as the dependent
variable and bacterial genera as explanatory variables. Fecal
microbial alpha diversity (Shannon index), richness and evenness
were calculated using the ‘diversity’ and ‘specnumber’ functions of
the veganRpackage anddifferences between groupswere evaluated
by Mann-Whitney test.
Clusters of co-occurring bacteria and their association with Sm+
or Sm- mice in each line (i.e. WT and HMA) were identified by
prediction of correlation networks, with microbial genera
represented as nodes, genera abundances as node size, and edges
representing positive associations among them. Networks were
generated by computing associations among microbial taxa using
Pearson’s correlation. The resulting pairwise correlations were
converted into dissimilarities and used to ordinate the nodes in a
two-dimensional plot by PCoA; thus, correlating nodes were located
in close proximity,while anti-correlatingnodeswereplaced at distant
locations in the network. Taxa abundances were associated with the
type of infection using Pearson’s correlation and the nodes were
colored based on the strength of this association.RESULTS
Worm and Egg Burdens in HMA
vs. WT Mice
All HMA mice of both experimental batches were successfully
infected with S. mansoni, whereas no adult worms or eggs were
recovered from two Sm-exp WT animals included in the second
experiment at post mortem; the latter were thus removed fromNovember 2020 | Volume 11 | Article 593838
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(p=0.017, t=2.67, df=16) and EPG of liver (p=0.008, t=3.02, df=16)
were observed inHMA compared toWTmice (cf. Figures 1A, B; cf.
Supplementary Table 1). Since differences in EPG of liver could be
explained by higher worm burdens observed in HMAmice (Figure
1C), changes to parasite fecundity are unlikely. No significant
differences were observed in the number of EPG of liver per female
between the two groups of mice (p=0.897, U=38.00; Supplementary
Table 1). Furthermore, the higher infection burdens observed in
HMA compared to WT mice were accompanied by significantly
higher levels of Schistosoma-specific antibodies in sera from HMA
animals (Supplementary Figures 1 and 2).
Diversity and Compositional Traits
Differentiate the Gut Microbial Profiles
of WT and HMA Mice at Baseline
The two rodent lines employed in this study were characterized by
marked differences in (i) the origin of the microbiome (wildtype vs.
heterologous from a human donor) and (ii) exposure to
environmental microbes (maintained under specific-pathogen
free [SPF] conditions vs. in isolation). We anticipated that these
profounddissimilaritiesmight significantly impact the composition
of the gut microbiota of each mouse line; therefore, we first
investigated structural and compositional differences between the
gut microbial communities of these rodent lines at baseline. Fecal
microbial profiles obtained from samples from Sm-WT andHMA
were clustered separately byPCoA,which led to the identificationof
a putative outlier sample in the former group (SupplementaryFrontiers in Immunology | www.frontiersin.org 5Figure 3). Dixon’s Q test for outliers, calculated on the Shannon
diversity of all Sm-WT mice, supported this hypothesis (p=0.031;
Q=0.66), and thus sequence data obtained from this sample were
removed prior to further analyses (Table 1). PCoA analysis of gut
microbial profiles of uninfected WT and HMA mice revealed
profound differences between the gut microbiota compositions of
these rodent lines (cf. Figure 2A). Notably, the gut microbiota
composition of HMAmice was highly homogenous, unlike that of
WT mice (Figure 2A). This observation was confirmed by
ANOSIM, which revealed a significantly higher Bray-Curtis
dissimilarity among WT compared to HMA mice (p=0.004, R=1;
Supplementary Figure 4). Significant differences in fecal microbial
alpha diversity were also detected between uninfected WT and
HMA (Figure 2B), with significantly reduced microbial richness
(p=0.004, U=0.0; Figure 2B) and evenness (p=0.004, F=0.0; Figure
3B) observed in the fecalmicrobiota ofHMAcompared toWTmice
(Figure 2B).
In addition to differences in microbial community structure,
significant dissimilarities were observed between the taxonomic
composition of the gut microbiota of WT and HMA mice prior to
parasite infection (Figures 2C–E and Supplementary Table 2). The
phyla Bacteroidetes and Firmicutes weremost abundant in the gut of
bothmouse lines (Figure 2C).However, in the gutmicrobiota ofWT
animals, similar proportions of these two phyla were observed
(measured as mean TSS-transformed relative abundance ±
standard deviation), i.e. 48.21 ± 3.61% Bacteroidetes compared
with 47.94 ± 3.84% Firmicutes. In contrast, the phylum
Bacteroidetes predominated in HMA mice, with 61.52 ± 3.52%A B
C
FIGURE 1 | Host microbiome affects susceptibility to Schistosoma mansoni infection. Mean number of (± standard error) male and female worms (A), eggs per
gram (EPG) of liver (B), and eggs per female worm (C) recovered from infected wild type (WT) and human microbiota-associated (HMA) mice at 50 days post
cercarial exposure. Horizontal lines represent significant differences between mouse lines: *p < 0.05; **p < 0.01.November 2020 | Volume 11 | Article 593838
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FIGURE 2 | The composition of the baseline gut microbiota differs extensively between naïve wild type (WT) and human microbiota-associated (HMA) mice.
(A) Principal Coordinate Analysis (PCoA) performed at amplicon sequence variant (ASV) level. (B) Differences in microbial alpha diversity; horizontal lines represent
significant differences between mouse lines: **p < 0.01. (C) Doughnut charts representing the mean relative abundances (TSS-transformed data) of gut microbial
phyla and genera identified in feces of naïve WT (outer ring) and HMA (inner ring) mice. Others = sum of all taxa individually representing >0.5% of the overall
microbial community. Unclassified = sum of all unclassified genera. (D) Percentage of bacterial taxa (from phylum to genus) for which significant differences were
detected between the gut of naïve WT and HMA mice, according to both LEfSe and ANOVA (see differentially abundant taxa in Supplementary Table 2).
(E) Percentage of taxa identified (from phylum to genus) solely detected in the gut microbiota of either WT or HMA mice, and in both rodent lines.Frontiers in Immunology | www.frontiersin.org November 2020 | Volume 11 | Article 5938386
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third most represented bacterial phylum in both rodent lines (1.72 ±
0.98% in WT and 6.70 ± 1.72% in HMA mice), followed by
Deferribacteres and Cyanobacteria in WT (0.86 ± 1.23% and
0.58 ± 0.64%, respectively), and Verrucomicrobia in HMA (0.95 ±
0.93%; Figure 2C). No Deferribacteres or Patescibacteria were
detected in the gut microbiota of HMAmice (Figure 2C). At genus
level, theLachnospiraceaeNK4A136groupwasmost abundant in the
gut of WT animals (12.41 ± 2.55%), followed by the genera
Bacteroides (10.23 ± 3.62%), Prevotella UCG-001 (5.11 ± 4.84%)
and Lactobacillus (4.28 ± 3.50%). In contrast, the genus Bacteroides
was predominant in the gut of HMAmice (38.31 ± 3.69%), followed
by Parabacteroides (10.82 ± 0.94%), Lachnospiraceae NK4A136
group (8.19 ± 4.89%) and Parasutterella (6.12 ± 1.75%) (Figure
2C). Furthermore, large differences in the proportions of unclassified
microbial genera were observed between mouse lines, together
representing 37.56% of the fecal microbial communities in WT
animals vs. the 9.73% in HMAmice (Figure 2C).
Differences in the abundances of individual microbial taxa in the
gut of uninfected WT and HMA mice were assessed by LEfSe and
ANOVAonCSS+log transformed16S rRNAsequencedata (Figures
2D, E and Supplementary Table 2A, B). In particular, significant
differences (LEfSe: LDA score (log10)>3; ANOVA p<0.05) were
detected in ~45% of the phyla, and >60% of the microbial classes,
orders, families and genera composing the gut microbiota of the two
mouse lines (Figure 2D; Supplementary Table 2). Among these, the
genera Eubacterium coprostanoligenes group and Oscillibacter, both
belonging to the family Ruminoccocaceae, were significantly more
abundant in the gut of WT mice, while several genera, including
Blautia, Roseburia, Clostridium sensu stricto 1, Bacteroides and
Parabacteroides, among others, showed greater abundances in
HMA animals (Supplementary Table 2).
Additionally, a large number of bacterial taxa were solely
detected in either WT or HMA (Figure 3; Supplementary Table
2). For instance, at genus level, >50% of the taxa identified in this
studywere exclusively detected in eitherWTorHMAmice (Figure
2E). Of these, Prevotellaceae UCG-001 (5.11% ± 4.84%) and
Lactobacillus (4.28% ± 3.50%) were exclusively detected in WT,
while Barnesiella (3.00 ± 1.10%) in HMAmice (Figures 2C and 3).
However, the majority of these taxa were low-abundant bacteria,
each representing <1% of the overall gut microbial population. In
particular, numerous ‘line-exclusive’ genera belonged to the family
Lachnospiraceae (Supplementary Table 2), the second most
abundant family in the gut of both mouse lines. Furthermore, the
orders Deferribacterales and Saccharimonadales, along with the
families Lactobacillaceae and Muribaculaceae were detected
exclusively in the gut of WT animals, whereas the orders
Slenomonadales and DTU014 were solely found in the gut of the
HMA hosts (Supplementary Table 2).
Schistosoma mansoni Infection Is
Associated With Differences in Gut
Microbiota Alterations Between HMA
and WT Mice
The extensive differences observed between the gut microbiota
composition of HMA andWTmice at baseline prevented us fromFrontiers in Immunology | www.frontiersin.org 7conducting direct comparisons between infected and uninfected
animals of these rodent lines; therefore, we next investigated the
impact of S.mansoni infection on the gutmicrobiota profile of each
host. Colonization by S. mansoni was associated with overall
changes in the gut microbiota composition of both WT and
HMA mice, as determined by CCA (WT: p=0.002, F=2.68; HMA:
p=0.001, F=4.65; Figure 4A). In both mouse lines, these changes
included a significant decrease in microbial alpha diversity post-
infection, as well as variations in the abundances of selected
populations of gut bacteria (Figure 4, Supplementary Figure 5
and Supplementary Table 3). Notably, the reduction in microbial
alpha diversity observed in Sm+WTmice (Shannon index [ASV],
p=0.006, U=2.0) was associated with a significant decrease in
evenness (p=0.002, U=0.0), whereas that observed in Sm+ HMA
mice (Shannon index [ASV], p=0.008, U=4.0) was linked to a
significant decrease in ASV richness (p=0.005, U=3.0) (Figure 4B).
Variations in the abundances of individual microbial taxa in the
gut of WT and HMAmice following infection by S. mansoni were
assessed byLEfSe andANOVAonCSS+log transformed 16S rRNA
sequence data (Supplementary Table 3A–C). Furthermore,
network analyses led to the identification of populations of gut
bacteria associated with infection by S. mansoni in eachmouse line
(Figure 4C), while information on the abundances of individual
microbial genera across all samples is shown in Figure 3. At day 50
p.i. significant alterations in the abundances of several families and
genera belonging mainly to the orders Clostridiales and
Bacteroidales were observed in Sm+ WT and HMA mice,
compared to Sm- (Supplementary Table 3). Within the
Clostridiales, members of the family Lachnospiraceae, such as
Lachnospiraceae UCG-006 and UCG-10, were significantly
reduced in the gut microbiota of WT mice following infection,
whileLachnospiraceaeFCS020 groupwasmore abundant in the gut
of these animals (Figure 4C and Supplementary Table 3). In the
HMA line, selected Lachnospiraceae, i.e. Shuttleworthia and
Eubacterium ventriosum group, were significantly reduced in the
gutmicrobiota of infected animals, whereas other genera, including
Moryella, Roseburia or Lachnoclostridium, were significantly
expanded (Figure 4C and Supplementary Table 3). Similarly,
several members of the family Ruminococcaceae were either
reduced or expanded in the gut microbiota of each mouse line
post-infection (Supplementary Table 3). For instance, the genus
Anaerotruncuswas negatively associated with Sm+WTmice based
on both ANOVA and network analyses; in contrast, a positive
correlation between the abundance of this bacterial genus and
helminth infection was observed in HMA rodents by both LEfSe
and network analyses (Figure 4C and Supplementary Table 3).
The family Clostridiaceae 1 was significantly associated with
infected and uninfected WT and HMA mice, respectively. In WT,
this finding was linked to a significant expansion of the genus
Candidatus Arthromitus following S. mansoni infection, while a
significant contraction in populations ofClostridium sensu stricto 1
was detected in Sm- HMA mice (Figure 4C and Supplementary
Table 3).
Among members of Bacteroidales whose abundances were
altered following S. mansoni infection, the genus Parabacteroides
was associated with helminth colonization in both mouse lines byNovember 2020 | Volume 11 | Article 593838
Corté s et al. Gut Microbiome and Schistosoma InfectionsFIGURE 3 | Microbial community composition of all fecal samples from Schistosoma mansoni-infected (Sm+) and uninfected (Sm-) wild type (WT) and human
microbiota associated (HMA) mice analyzed in this study, at genus level. In the heatmap, columns represent samples and rows represent genera abundance, both
ordered by hierarchical clustering. Explanatory variables (i.e. mouse line and infection status) are presented as a separate heatmap at the top of the figure.Frontiers in Immunology | www.frontiersin.org November 2020 | Volume 11 | Article 5938388
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C
FIGURE 4 | Infection by Schistosoma mansoni is associated with significant alterations of the fecal microbiota composition of wild type (WT) and human microbiota-
associated (HMA) mice. (A) Canonical Correlation Analysis (CCA) of microbial profiles of WT and HMA mice, performed at amplicon sequence variant (ASV) level and
clustered according to infection status [i.e. infected (Sm+) vs. uninfected (Sm-)]. (B) Differences in microbial alpha diversity between the fecal microbial profiles of
infected and uninfected animals in each rodent line; horizontal lines represent significant differences between rodent lines: **p < 0.01. (C) Clustering of microbial
genera co-occurring in the fecal microbiota of infected and uninfected WT and HMA mice (the full list of differentially abundant taxa is available from Supplementary
Table 3).Frontiers in Immunology | www.frontiersin.org November 2020 | Volume 11 | Article 5938389
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detected significant infection-associated increases in populations of
Parabacteroides in HMA animals (Supplementary Table 3).
Furthermore, while significant expansions of populations of
Bacteroides and Alistipes were observed in the gut of infected WT
mice (Figure 4C and Supplementary Table 3), network analysis
revealed a negative association between these genera and infection
by S. mansoni in HMA animals (Figure 4C). Nevertheless,
significant differences in intestinal populations of Bacteroides or
Alistipes were not detected between Sm+ and Sm- HMA mice by
either LEfSe or ANOVA (Supplementary Table 3). In addition,
within the Bacteroidales, LEfSe and network analyses detected
positive associations between the genera Odoribacter and
Rikenella (the latter also supported by ANOVA) and S. mansoni
infection in WT mice (Figure 4C and Supplementary Table 3). In
HMA mice, however, infection was associated with significant
expansions of bacteria within the family Barnesiellaceae, and the
related genera Barnesiella and Coprobacter (detected by LEfSe and
network analysis), as well as the genus Butyricimonas (detected by
LEfSe, ANOVA and network analysis) (Figure 4C and
Supplementary Table 3); notably, these taxa were solely detected
in the gut of HMA mice (Supplementary Table 2).
Besides changes in the abundances of members of the
Clostridiales and Bacteroidales, S. mansoni infection was associated
with significant alterations in populations of Alphaproteobacteria,
and of the genus Azospirillum sp. 47 25 in particular, which was
positively and negatively linked to parasite colonization in WT and
HMA mice, respectively (Figure 4C and Supplementary Table 3).
Furthermore, in HMA animals, helminth infection was linked to
significant reductions in populations of the class Bacilli (and order
Bacillales), and expansions of the class Negativicutes (order
Selenomonadales, family Acidaminococcaceae and genus
Phascolarctobacterium); the latter bacterial class (and related taxa)
was solely detected in the gut microbiota of HMA mice
(Supplementary Table 3).
For each rodent line, correlations between the abundances of
individual gut bacteria and infection burdens (i.e. worm counts and
EPG of liver) were investigated by multiple regression. While the
genera Lachnospiraceae UCG-006 and Family XIII UCG-001 were
negatively correlatedwithwormcounts andEPGof liver inWTmice,
the abundances of Bacteroides and Rikenella were positively
correlated with infection burdens (worm counts and/or EPG of
liver) in Sm+ WT hosts (Supplementary Table 4). In contrast, in
HMA mice, parasite burdens were negatively correlated with fecal
populations of Turicibacter, Shuttleworthia, Ruminococcus 1 and
Clostridium sensu stricto 1, and positively correlated with those of
Moryella and Lachnoclostridium, among other genera. The complete
list of bacterial genera whose abundances correlated with infection
burdens in either line is available from Supplementary Table 4.
These findings were consistent with data obtained by LEfSe
(Supplementary Table 3A), ANOVA (Supplementary Table 3B,
C) and/or taxa correlation network analyses (Figure 4C).
Fecal Bacteria Correlated With Infection
Burdens in Both WT and HMA Mice
While the study of the alterations of the gut microbial composition
associated with S. mansoni infection in HMA and WT miceFrontiers in Immunology | www.frontiersin.org 10revealed substantial differences between rodent lines, some
common traits were identified. In order to identify fecal microbial
taxa consistently associated with infection in both mouse lines, the
LEfSe workflow was applied to all metagenomics datasets, while
controlling for both infection status and rodent line. In accordance
with the findings obtained from individual analyses of each rodent
line, the genus Eubacterium coprostanoligenes group was positively
associated to S. mansoni infection when the two variables (i.e.
‘infection status’ and ‘mouse line’) were considered, whereas the
genera Ruminococcus 1, Butyricicoccus and Family XIII UCG-001,
among others, were associated to Sm- samples (Supplementary
Table5). Correlations between the fecal abundancesofkeybacterial
genera identified by LEfSe with worm counts and EPGof liver were
investigated by multiple regression analysis. Significant negative
associations were detected between infection burden and fecal
abundances of Ruminococcus 1, Butyricicoccus, Family XIII UCG-
001 and Family XIII AD3011 in both rodent lines, while a positive
correlation was observed between the abundance of Eubacterium
coprostanoligenes group and total worm counts (Supplementary
Table 5B). Linear regression data of worm burdens/EPG of liver vs.
taxa abundance in the two rodent lines showed similar trends to
those observed in eachWT and HMA (Supplementary Figure 6).DISCUSSION
Animal models of infection are used extensively to address causal
relationships between helminth colonization, alterations in gut
microbial composition, and changes in the immune and/or
metabolic functions of the host (12). Nevertheless, helminth-gut
microbiota interactions are highly heterogeneous depending on the
host-parasite pair under consideration (4). Thus, comparing data
between different host-parasite systems, even when these involve
the same helminth species, may lead to misinterpretations. On the
other hand, studies on naturally infected humans may provide data
on associations between gut microbial composition and infection
with one or more parasites (33); nevertheless, such studies often
lack proof of causality between gut microbial signatures and
susceptibility to, or pathophysiology of, infection (34, 35).
Therefore, complementary studies involving naturally-infected
human populations in endemic areas and experimental animal
models are pivotal to advance our knowledge of the contribution of
the gut microbiota in human parasitic diseases. Towards this aim,
novel animal models of infection involving mice colonized by gut
microbes of human origin (i.e. HMA mice) may offer unique
research opportunities. Thus far, these experimental systems have
been applied to investigations of the contribution of human
dysbiotic microbiomes to immune- and metabolic-mediated
diseases such as diabetes, obesity, inflammatory bowel disease
and cancer (34). In this study, HMA mice were used to explore
the links between S. mansoni infections and host gut microbiota
composition. To the best of our knowledge, this is the first study
investigating the relationships between helminth infections and the
gut microbiota of the definitive host via the use of HMA mice.
Furthermore, prior to our study, no data was available on the
associations between the baseline composition of the host gut
microbiota and host susceptibility to Schistosoma colonizationNovember 2020 | Volume 11 | Article 593838
Corté s et al. Gut Microbiome and Schistosoma Infectionsand/or pathogenicity. Signatures of gut microbial dysbiosis (i.e.
expanded Proteobacteria) have been associated with S.
haematobium infection in adolescents from an endemic region
(17), as well as to overt clinical signs of schistosomiasis mansoni
(i.e. blood in stool and/or splenomegaly) and adverse effects to
praziquantel treatment in children (16). However, it remains
unclear whether dysbiosis represents an outcome of infection or
a risk factor leading to the development of severe disease in
young susceptible individuals (17).
In this study, associations between the outcome of S. mansoni
infections and the gut microbiota composition at the time of
infection were detected in WT and HMA mice. The baseline gut
microbiota profile of HMA mice is influenced by multiple
evolutionary and ecological factors that impact on the
colonization, establishment and growth of selected groups of
bacteria (among other microbes) at the expense of others,
generally resulting in intestinal dysbiosis (34). Interestingly, in our
study, HMA mice were colonized by higher worm burdens –
resulting in higher egg loads in the liver – and displayed an
enhanced production of anti-S. mansoni SEA antibodies than
WT animals, suggesting the occurrence of an association between
baseline gut microbiota composition and susceptibility to parasite
infection. Of note, gut microbial dysbiosis in naïve HMA mice was
characterized by enlarged proportions of Proteobacteria and low
microbial richness and overall alpha diversity (compared to WT
animals), which is partially consistent with data from studies
performed in humans from endemic areas, where no alterations
in alpha diversity had been reported (16, 17).
While the mechanisms underpinning the higher worm and egg
burdens observed in HMA hosts are yet to be discovered, one
hypothesis might be linked to the modified immune system that
characterizes these mice. Indeed, the gut microbiome of vertebrate
animals is essential for the maturation and proper functioning of
their immune system (36, 37). Germ-free mice are known for their
deficient innate and adaptive immunity (38) that, in turn, had been
linked to enhanced susceptibility to S. mansoni colonization (39).
Similarly, HMAmice have been reported to display altered immune
responses and susceptibility to intestinal bacterial infections (38, 40,
41). In humans, gut microbial dysbiosis has been associated with a
number of pathological conditions (42); importantly, in resource-
limited settings, such as those where schistosomiasis is endemic
(13), young children are often affected by environmental enteric
dysfunction, a multifactorial disorder associated with early
childhood malnutrition, growth retardation and impaired
immune function (43, 44). Intestinal dysbiosis is key to the
pathogenesis of environmental enteric dysfunction (43, 44);
therefore, causal relationships may occur between gut microbial
imbalances in children from these areas and susceptibility to
schistosomiasis that deserve to be thoroughly investigated.
The large number of bacterial taxa that were solely detected
in either HMA or WT mice is noteworthy and, together with
the substantial differences in the relative proportions of several
other bacteria detected between the two rodent lines, might be
linked to the different burdens of S. mansoni observed in these
experiments. Indeed, altered populations of immune-
modulatory bacteria (i.e. lactobacilli) in the mouse gut haveFrontiers in Immunology | www.frontiersin.org 11been linked to differences in immune responses and
susceptibility to infection by the gastrointestinal helminth
Heligmosomoides polygyrus (6). In our study, Lactobacillaceae
(including the genus Lactobacillus) were only detected in the
gut of WT mice, although populations of these bacteria were
not altered by infection. Previously, transient expansions of
Lactobacillus were reported in the gut of Swiss-Webster mice
exposed to large numbers of S. mansoni cercariae (19). The role
of lactobacilli in regulating S. mansoni infection remains,
however, unknown, and further studies are necessary in order
to ascertain whether the absence of these bacteria in the gut of
HMA mice might be linked to the higher infection burdens
observed in these animals.
The genus Barnesiella was solely identified in the feces of
HMA mice, and was significantly expanded in the gut of infected
animals. While members of this genus have been regarded as
immunomodulatory, current evidence is inconsistent. Expanded
populations of Barnesiella spp. have been linked to Th1
environments in diverse murine models (45–47). In contrast,
in humans, negative correlations between fecal abundances of
Barnesiella and the ability of peripheral blood mononuclear cells
to produce IFN-g following stimulation with either
lipopolysaccharide or Bacteroides fragilis have been described
(48). IFN-g has been reported to mediate protection against S.
mansoni infection in vaccine studies (49–51). Moreover, Th1
responses are dominant during pre-patent schistosomiasis (52).
Therefore, given the known links between Barnesiella and Th1-
mediated immunity in mice and humans, the potential role(s) of
this genus of bacteria in modulating the response against
S. mansoni in HMA mice merit(s) further investigations.
Structural and compositional differences between the gut
microbiota of WT and HMA mice at baseline might explain the
large dissimilarities observed in infection-associated changes in
microbial profiles. However, some common traits were noted. For
instance, the genus Ruminococcus 1 (the abundance of which was
negatively correlated with infection burdens in both WT and
HMA mice) includes mucin-degrading bacteria (53, 54) whose
growth might be affected by variations in mucosal carbohydrate
availability (55). Alterations in intestinal mucus production and
glycosylation are known to occur during gastrointestinal helminth
infections (56–58) and, given the essential role of the IL-4/IL-13
pathway in goblet cell hyperplasia, mucus secretion and
glycosylation (59), are likely to arise during intestinal
schistosomiasis. Therefore, it is plausible that reduced
populations of Ruminococcus 1 in the gut of Sm+ mice might be
linked to changes in mucin glycan composition; this, in turn,
might be associated to egg-induced immunity and disruption of
the intestinal barrier. On the other hand, selected Ruminococcus
spp. play roles in the breakdown of dietary polysaccharides and
production of immunomodulatory short-chain fatty acids
(SCFAs) (60, 61). Other populations of SCFAs-producing
bacteria, such as Butyricicoccus (62), and the genera
Shuttleworthia (63) and Intestinimonas (64, 65), were also
negatively correlated with S. mansoni infection burdens (the
latter two in HMA mice only); thus, reductions in the
abundances of these populations of gut bacteria might lead to anNovember 2020 | Volume 11 | Article 593838
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infected animals (66).
While these findings suggest the occurrence of associations
between changes in gut microbiota composition and alterations
of host immune and intestinal barrier function over the course of
schistosomiasis, the profound differences between the gut
microbial profiles of HMA and WT mice call for caution when
selecting bacterial candidates for follow-up experiments aimed at
ascertaining the role of the host gut microbiota in modulating
immunity to infection. For instance, despite the abovementioned
reduction in several SCFA-producing bacteria in the intestines of
both Sm+ WT and HMA mice, butyrate-producing Roseburia
(67) were significantly more abundant in the gut of HMA hosts
at baseline, and were further expanded post schistosome
infection. Hence, similar changes in gut microbial composition
of both lines might not result in comparable immune responses
in each host. Nevertheless, laboratory rodent lines characterized
by different susceptibility to infection, and with predefined
profiles of immunomodulatory gut bacteria might be useful to
investigate the contribution of the host gut flora to resistance to
Schistosoma infection via, for instance, fecal transplants or gut
recolonization with selected bacteria (68). In particular, HMA
mice might represent invaluable models for mechanistic studies
aimed to reveal causal relationships between alpha diversity and/
or selected populations of immunomodulatory bacteria (and
other microscopic inhabitants of the gut including prokaryotes,
eukaryotes and viruses) and immunity to infection.
Furthermore, given that HMAmice are derived from germ-free
animals and maintained under strict conditions of isolation, it is
tempting to speculate that, besides the gut microbiota, microbial
communities colonizing other organs such as the skin or the
respiratory tract might also be dysbiotic. The skin microflora plays
important roles in shaping cutaneous immunity and preventing
pathogen colonization (69), while interactions between the gut and
lung microbiome (i.e. the so-called gut-lung axis) have been linked
to alterations of the lung immune function (70). The contributing
roles of skin and lung microbiomes in regulating immunity to and
survival of schistosomulae are yet to be investigated; this, together
with the current lack of data on the composition of the dermal and
respiratory microbiota of HMA mice, prevents us from further
speculating about the potential role(s) of skin and/or lung
dysbiosis in enhanced susceptibility to S. mansoni infection.
Nevertheless, our results suggest that HMA mouse models could
be useful to test the contribution of such microbial communities to
the defense against the juvenile stages of Schistosoma spp.CONCLUSIONS AND FUTURE
PERSPECTIVES
Overall, our results suggest that the baseline composition of the host
gut microbiome might impact host susceptibility to S. mansoni
colonization, as well as infection-associated changes in gut microbial
profiles. However, further studies are necessary to ascertain the
impact that gut microbial dysbiosis (i.e. reduced alpha diversity)
and/or selected human microbes exerts on S. mansoni infection
rates. In particular, such studies should include (i) experimentalFrontiers in Immunology | www.frontiersin.org 12infections of additional HMA mouse lines, (ii) groups of control
rodents derived from germ-free mice transplanted with the fecal
microbiota of WT mice, and (iii) antibiotic-treated WT mice.
Moreover, predictive models linking infection burdens to the
abundances of key gut microbes and/or alpha diversity prior to
infection could be useful to identify gut microbial features that
might facilitate parasite colonization. This knowledge will underpin
future mechanistic studies to untangle the complex interactions
between the gut microbiome, the host immune response and the
outcome of schistosome infection.DATA AVAILABILITY STATEMENT
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SUPPLEMENTARY FIGURE 1 | IgG responses to Schistosoma mansoni
soluble egg antigen (SEA) in the sera of wild type (WT) and human microbiota-
associated (HMA) mice. Lines connect samples collected from individual mice fromNovember 2020 | Volume 11 | Article 593838
Corté s et al. Gut Microbiome and Schistosoma Infectionstwo independent batches of infection (i.e., B1 = dashed, and B2 = solid). OD =
Optical density. Asterisks indicate statistically significant differences between the
sera of infected (Sm+) and uninfected (Sm-) mice (*p<0.05).
SUPPLEMENTARY FIGURE 2 | IgM responses to Schistosoma mansoni
soluble egg antigen (SEA) and total IgE in the sera of wild type (WT) and human
microbiota-associated (HMA) mice. Lines connect samples collected from individual
mice from two independent batches of infection (i.e., B1 = dashed, and B2 = solid).
OD = Optical density. Asterisks indicate statistically significant differences between
the sera of infected (Sm+) and uninfected (Sm-) mice (*p<0.05).
SUPPLEMENTARY FIGURE 3 | Principal Coordinate Analysis (PCoA)
performed at amplicon sequence variant (ASV) level (A) and estimated microbial
alpha diversity (B) of microbial profiles of uninfected wild type mice (WT); red circles
indicate the outlier sample identified in this experimental group, which was removed
prior to further downstream processing. (C) PCoA (ASV) depicting the microbial
profiles of uninfected human microbiota-associated mice (HMA).Frontiers in Immunology | www.frontiersin.org 13SUPPLEMENTARY FIGURE 4 | Microbial beta diversity of uninfected wild type
(WT) and human microbiota-associated (HMA) mice. Differences between mouse
lines were assessed by ANOSIM on Bray-Curtis dissimilarities (**p<0.01). Between
= beta diversity between groups.
SUPPLEMENTARY FIGURE 5 | Gut microbial profiles of wild type (WT) and
human microbiota-associated (HMA) mice following infection by Schistosoma
mansoni. Doughnut charts representing the mean relative abundances (TSS-
transformed data) of gut microbial genera detected in the feces of uninfected (outer
ring) and S. mansoni-infected (inner ring) WT and HMA mice. Others = sum of all
genera individually representing less than 0.5% of the overall microbial community.
Unclassified = sum of all unclassified genera.
SUPPLEMENTARY FIGURE 6 | Correlations between Schistosoma mansoni
worm burdens and eggs per gram (EPG) of liver, and abundances of selected
bacterial genera in feces of wild type (WT) and human microbiota associated (HMA)
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